/CSL
CSL
Updated 25 May 08:16 am
$98.47
CSL LIMITED
1D-2.23%
1M-8.95%
1Y-44.29%
Track your position in CSL
Sign in to TradeLedgr to record trades in CSL (CSL LIMITED) with parcel-level precision and ATO-compliant reporting.
Recent Announcements
18 May 2026 6:51 AM
Appendix 3Y - Alison Watkins204KB
Change of Director's Interest Notice
10 May 2026 10:15 PM
Interim CEO 90 Day Review and Financial Update1499KB
Profit Guidance
07 May 2026 7:11 AM
Change in substantial holding2984KB
Change in substantial holding
07 May 2026 6:33 AM
Notification of cessation of securities - CSL12KB
Appendix 3H (Notification of cessation of securities)
06 May 2026 7:09 AM
Notification of cessation of securities - CSL12KB
Appendix 3H (Notification of cessation of securities)
Fundamentals
P/E Ratio
24.64x
Div Yield
434.94%
EPS
$3.9761
Avg Vol
1.4M
52W High
$275.790
52W Low
$93.640
Company Profile
Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
Corporate WebsiteFinancial History
2025A
$3002.0M profit
$15558.0M rev
2024A
$2642.0M profit
$14800.0M rev
2023A
$2194.0M profit
$13310.0M rev